| HOME >> BIOLOGY >> TECHNOLOGY |
ALPHARETTA, Ga., Sept. 25 /PRNewswire/ -- Identity Sciences, LLC (IDS), with its strategic science partner the Idaho National Laboratory (INL), has been awarded a 2008 R&D 100 Award for AbP ID(TM), a new groundbreaking forensic human identification test. The new product, scheduled to be available to forensic labs in late 2009 or early 2010, will be used as a screening tool for DNA and can deliver accurate, reliable results in as little as two hours.
The R&D 100 Awards are considered to be the most prestigious honor in Applied Research. Each year the Award recognizes the 100 most technologically significant new products, processes, materials and software developed throughout the world. It is the only industry-wide competition rewarding the practical applications of science.
Awards are based on each achievement's technical significance, uniqueness and usefulness compared to competing projects and technologies. The Chicago Tribune calls the award "The Oscars of Invention." Previous winners include the fax machine, the Automated Teller Machine (ATM), the cancer drug Taxol, the Nicoderm anti-smoking patch and HDTV.
"Identity Sciences is honored to have AbP ID judged to be one of the top 100 scientific achievements of 2008," says Gene Venesky, CEO of Identity Sciences. "We believe AbP ID will make significant contributions and advancements, not only in the field of forensics, but in homeland security, personnel recovery and healthcare, both nationally and internationally," he adds.
The AbP ID test analyzes Individual Specific Auto-antibodies (ISAs),
found in all human body tissues and fluids. It is unlike the current
standard forensic testing method which reads DNA in human cells. The AbP ID
test can determine whether the antibody profile of the evidence found at a
crime scene matches the profile of a suspect. The initial product release
will use blood serum and dried blood, and will provide results in just two
hours. Other AbP ID tests
'/>"/>
| SOURCE Identity Sciences, LLC Copyright©2008 PR Newswire. All rights reserved |